Compare Zepbound and Wegovy to understand how one hormone vs two impacts weight loss, appetite control, side effects, and ...

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

It is unclear what the company intends to charge for the vials, the report said. ・Unlike Novo, Eli Lilly and Company already ...

Novo Nordisk (NYSE:NVO) announced that it is planning to introduce its weight-loss medication Wegovy in vials. “We are ...

Feb 11 (Reuters) - Novo Nordisk said on Wednesday it plans to launch its weight-loss pill Wegovy in vials. "We are exploring ...

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity ...

By Robin Respaut SAN FRANCISCO, Feb 11 (Reuters) - Among early users of Novo Nordisk'snew Wegovy weight-loss pill, 36% had no prior experience taking a GLP-1 medication, a new study from the health ...

Telehealth company Hims & Hers unleashed a wild few days in the obesity drug market last week when it introduced a cheap, compounded version of Novo Nordisk's new Wegovy pill.

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

Medications such as Wegovy and Zepbound will no longer be covered for weight loss, although GLP-1 drugs for diabetes will still be approved.